Strata Critical Medical, Inc.
SRTA Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 60.7%, EPS fell 140.0% and free cash flow grew 150.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow SRTA
Strata Critical Medical, Inc. (SRTA) Altman Z-score
Strata Critical Medical, Inc.'s Altman Z-score for fiscal 2025 is 5.25, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 5.25 | (0.35) |
| FY2024 | 5.60 | 3.09 |
| FY2023 | 2.51 | (0.69) |
| FY2022 | 3.19 | (2.48) |
| FY2021 | 5.68 | (0.12) |
| FY2021 | 5.80 | (14.12) |
| FY2020 | 19.91 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.33 | — | 0.39 | |
| Retained earnings / total assets | (0.45) | — | −0.63 | |
| EBIT / total assets | (0.07) | — | −0.23 | |
| Market value of equity / total liabilities | 8.51 | — | 5.11 | |
| Sales / total assets | 0.61 | — | 0.61 | |
| Altman Z-score | Safe zone | 5.25 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 6.54 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| MCTA Charming Medical Limited compare | 61.6× |
| SRTA Strata Critical Medical, Inc. | 5.3× |
| INNV InnovAge Holding Corp. compare | 4.6× |
| NUTX Nutex Health Inc. compare | 3.3× |
| USPH U.S. Physical Therapy, Inc. compare | 2.1× |
| STLN Starling Oncology, Inc. compare | 1.4× |
| CYH Community Health Systems, Inc. compare | 1.0× |
| AUNA Auna S.A. compare | 1.0× |
| AIRS AirSculpt Technologies, Inc. compare | 0.9× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets